参考文献/References:
[1] Groop PH,Thomas MC,Moran JL,et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes [J]. Diabetes,2009,58（7）：1651-1658.
[2] Wang XM,Yao M,Liu SX,et al. Interplay between the Notch and PI3K/Akt pathways in high glucose-induced podocyte apoptosis [J]. Am J Physiol Renal Physiol,2014,306（2）：F205-F213.
[3] Greenwald I,Kovall R. Notch signaling：genetics and structure [J]. WormBook,2013,17：1-28.
[4] Kopan R,IIagan MX. The canonical Notch signaling pathway： unfolding the activation mechanism [J]. Cell,2009,137（2）：216-233.
[5] Arnett KL,Hass M,McArthur DG,et al. Structural and mechanistic insights into cooperative assembly of dimeric Notch transcription complexes [J]. Nat Struct Mol Biol,2010,17（11）：1312-1317.
[6] Liu Z,Chen S,Boyle S,et al. The extracellular domain of Notch2 increases its cell-surface abundance and ligand responsiveness during kidney development[J]. Dev Cell,2013,25（6）：585-598.
[7] Murea M,Park JK,Sharma S,et al. Expressions of Notch pathway ptoteins correlate with albuminuria,glomerulosclerosis,and renal function [J]. Kidney Int,2010,78（5）：514-522.
[8] Boulos N,Helle F,Dussaule JC,et al. Notch3 is essential for regulation of the renal vascular tone [J].Hypertension,2011,57（6）：1176-1182.
[9] Yan M,Callahan CA,Beyer JC,et al. Chronic DLL4 blockade induces vascular neoplasms[J]. Nature,2010,463（7282）：E6-E7.
[10] Sharma M,Callen S,Zhang D,et al. Activation of Notch signaling pathway in HIV-associated nephropathy[J].AIDS,2010,24（14）：2161-2170.
[11] Sharma M,Magenheimer LK,Home T,et al. Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy[J]. Am J Physiol Renal Physiol,2013,304（8）：F1127-F1136.
[12] Huang R,Zhou Q,Veeraragoo P,et a1. Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the γ-secretase inhibitor DAPT has a nephroprotective effect[J].Ren Fail,2011,33（2）：207-216.
[13] Gupta S,Li S,Abedin MJ,et a1. Effect of Notch activation on the regenerative response to acute renal failure[J]. Am J Physiol Renal Physiol,2010,298（1）：F209-F215.
[14] Sirin Y,Susztak K. Notch in the kidney: development and disease [J]. J Pathol,2012,226（2）：394-403.
[15] Bjornstad P,Snell-Bergeon JK,Rewers M,et al. Early diabetic nephropathy：a complication of reduced insulin sensitivity in type 1 diabetes [J]. Diabetes Care,2013,36（11）：3678-3683.
[16] Shimajiri Y,Kosaka Y,Scheel DW,et al. A mouse model for monitoring islet cell genesis and developing therapies for diabetes [J]. Dis Model Mech,2011,4（2）：268-276.
[17] Niranjan T,Murea M,Susztak K. The pathogenic role of Notch activation in podocytes[J]. Nephron Exp Nephrol,2009,111（4）：e73-e79.
[18] Kato H,Susztak K. Repair problems in podocytes：Wnt,Notch, and glomerulosclerosis[J]. Semin Nephrol,2012,32（4）：350-356.
[19] Lin CL,Wang FS,Hsu YC,et al.Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy [J]. Diabetes,2010,59（8）：1915-1925.
[20] Gao F,Yao M,Shi Y,et al. Notch pathway is involved in high glucose-induced apoptosis in podocytes via Bcl-2 and p53 pathways [J]. J Cell Biochem,2013,114（5）：1029-1038.
[21] Hills CE,Squires PE. TGF-beta1-induced epithelial-to-mesen-
chymaltransition and therapeutic intervention in diabetic nephropathy [J]. Am J Nephrol,2010,31（1）：68-74.
[22] Djudjaj S,Chatziantoniou C,Raffetseder U,et al. Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury [J]. J Pathol,2012,228（3）：286-299.
[23] Liu L,Gao C,Chen G,et al. Notch signaling molecules activate TGF-β in rat mesangial cells under high glucose conditions [J]. J Diabetes Res,2013,2013：979702.
[24] Thomas JL,Baker K,Han J,et al. Interactions between VEGFR and Notch signaling pathways in endothelial and neural cells [J]. Cell Mol Life Sci,2013,70（10）：1779-1792.
[25] Cao L,Arany PR,Kim J,et al. Modulating Notch signaling to enhance neovascularization and reperfusion in diabetic mice [J]. Biomaterials,2010,31（34）：9048-9056.
[26] Kavanagh D. McKay GJ. Patterson CC,et al.Association analysis of Notch pathway signalling genes in diabetic nephropathy [J]. Diabetologia,2011,54（2）：334-338.
[27] McCarthy MI,Zeggini E. Genome-wide association studies in type 2 diabetes [J]. Curr Diab Rep,2009,9（2）：164-171.
相似文献/References:
[1].2007年糖尿病新进展学习班将举办[J].国际内分泌代谢杂志,2007,(04):226.
[2]李英,段惠军.Raf/MEK/ERK信号转导通路在糖尿病肾病发生发展中的作用[J].国际内分泌代谢杂志,2007,(04):264.
[3]张红 章向成 朱大龙.炎性反应与糖尿病肾病[J].国际内分泌代谢杂志,2015,(01):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
Zhang Hong*,Zhang Xiangcheng,Zhu Dalong..Role of inflammation in diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
[4]邵滢,王秋月.Mir-217/Sirt1通路与糖尿病肾病[J].国际内分泌代谢杂志,2015,(02):124.[doi:10.3760/cma.j.issn.1673-4157.2015.02.014]
Shao Ying,Wang Qiuyue..Mir-217 / Sirt1 pathway and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):124.[doi:10.3760/cma.j.issn.1673-4157.2015.02.014]
[5]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[6]任慧雯,王秋月.Epac-Rap1与糖尿病肾病[J].国际内分泌代谢杂志,2015,(03):170.[doi:10.3760/cma.j.issn.1673-4157.2015.03.007]
Ren Huiwen,Wang Qiuyue..Epac-Rap1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):170.[doi:10.3760/cma.j.issn.1673-4157.2015.03.007]
[7]邵滢,王秋月.MiRNA-150与糖尿病肾病[J].国际内分泌代谢杂志,2015,(03):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
Shao Ying,Wang Qiuyue..MiRNA-150 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
[8]陈堃,刘超,陈国芳,等.糖尿病肾病诊断标志物研究进展[J].国际内分泌代谢杂志,2015,(03):176.[doi:10.3760/cma.j.issn.1673-4157.2015.03.009]
Chen Kun,Liu Chao,Chen Guofang,et al.Urinary biomarkers for diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):176.[doi:10.3760/cma.j.issn.1673-4157.2015.03.009]
[9]任慧雯,王秋月.Vasohibin-1与糖尿病肾病[J].国际内分泌代谢杂志,2015,(04):246.[doi:10.3760/cma.j.issn.1673-4157.2015.04.008]
Ren Huiwen,Wang Qiuyue..Vasohibin-1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):246.[doi:10.3760/cma.j.issn.1673-4157.2015.04.008]
[10]安丽,王秋月.Visfatin与胰岛素抵抗及糖尿病肾病的发病机制[J].国际内分泌代谢杂志,2015,(04):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]
An Li,Wang Qiuyue..Visfatin in the pathogenesis of insulin resistance and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]